Maharashtra FDA issues notices to Vimal Elaichi endorsers over surrogate promotion claims
The Maharashtra FDA has issued show-cause notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff over alleged surrogate advertising for Vimal Elaichi. The endorsers have 15 days to respond and are reportedly asked to remove promotional content and submit campaign documents.
What happened
Maharashtra FDA issued show-cause notices to Vimal Elaichi endorsers Shah Rukh Khan, Ajay Devgn and Tiger Shroff over alleged surrogate pan masala promotion,
Key facts
- 15 days
- Rs 10 lakh
- 2018
- 2019
Why this matters
Any partnership, licensing or media deal involving Vimal Elaichi should now include enhanced regulatory diligence, morality clauses and clear responsibility for advertising-compliance liabilities.
What to watch
- Whether Shah Rukh Khan, Ajay Devgn and Tiger Shroff submit responses, remove content or publicly distance themselves within 15 days.
- FDA findings on whether Vimal Elaichi branding, packaging or campaign assets are materially linked to Vimal pan masala/tobacco products.
- Any show-cause notices, penalties or advisories issued to the brand owner, ad agency, broadcasters, streaming platforms or digital platforms.
- Similar enforcement by other state FDAs, the Central Consumer Protection Authority, ASCI or the Ministry of Information and Broadcasting.
- Changes in celebrity contracts or campaign pauses by competing pan masala, gutkha-adjacent and mouth-freshener brands.
- Freeze or audit all Vimal Elaichi creative for visual, verbal, packaging and brand-linkage cues that could imply pan masala or tobacco promotion.
- Prepare a documented product, distribution, sales and media-plan defense demonstrating independent FMCG positioning.
- Secure rapid takedown workflows with platforms, broadcasters, retailers and outdoor-media partners before any formal directive expands.
- Rework endorsement contracts to include regulatory cooperation, content-removal obligations and indemnity provisions.
- Competitors should review surrogate-brand architecture and shift spend toward product-specific, compliant communication before scrutiny spreads.